Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

109.84 -0.30 (-0.27%)
Streaming Delayed Price Updated: 11:34 AM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
61 62 Next >
News headline image
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26 ↗
Bloomberg 
Via Benzinga
News headline image
Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years ↗
 
Via Benzinga
News headline image
Pfizer CEO Contracts COVID-19 Infection For Second Time ↗
Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said he had tested positive for COVID-19. 
Via Benzinga
News headline image
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges ↗
Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the... 
Via Benzinga
News headline image
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine ↗
 
Via Benzinga
News headline image
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna ↗
 
Via Benzinga
News headline image
Why Is Novavax (NVAX) Stock Falling Today? ↗
Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again. 
Via InvestorPlace
News headline image
Nikola, Super Micro Computer And Other Big Losers From Monday ↗
U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
Check Out What Whales Are Doing With BNTX ↗
Someone with a lot of money to spend has taken a bullish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
News headline image
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today? ↗
Vaccine stocks are taking it on the chin following President Joe Biden's comments that the "pandemic is over." What now? 
Via InvestorPlace
News headline image
Why BioNTech, Moderna And Novavax Shares Are Diving ↗
BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo 
Via Benzinga
News headline image
The Silver Lining For Pfizer, Moderna In This Month's IBD/TIPP Poll ↗
The companies recently launched their updated Covid booster shots. 
Via Investor's Business Daily
News headline image
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report ↗
 
Via Benzinga
News headline image
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗
 
Via Benzinga
News headline image
Moderna, BioNTech Jump After CDC Green-Lights Updated Covid Boosters ↗
These new shots target the BA.4 and BA.5 subvariants of omicron. 
Via Investor's Business Daily
News headline image
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines ↗
Health Canada has approved Moderna Inc's (NASDAQ: 
Via Benzinga
News headline image
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash... ↗
Wall Street Journal 
Via Benzinga
News headline image
Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News ↗
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use... 
Via Benzinga
News headline image
Pfizer, Moderna Nab FDA Authorization For Updated Covid Boosters ↗
Boosters are recommended two months out from the last shot. 
Via Investor's Business Daily
News headline image
Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30 ↗
Reuters Taiwan’s China Airlines Orders 16 Boeing 787s 
Via Benzinga
News headline image
US Stock Futures Higher Ahead Of Economic Data, Fed Speakers ↗
Pre-open movers U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the... 
Via Benzinga
News headline image
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report ↗
Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday. 
Via Benzinga
News headline image
Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine ↗
 
Via Benzinga
News headline image
Moderna Claims Pfizer, BioNTech Stole Its Patented Tech In Covid Shot ↗
The lawsuit alleges Comirnaty violates Moderna's patents from 2010-16. 
Via Investor's Business Daily
News headline image
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know ↗
Moderna Inc (NASDAQ: MRNA) has  
Via Benzinga
News headline image
Pfizer And Moderna Are In A Race With Omicron; Will The Vaccine Stocks Be Too Late? ↗
The companies hope to launch updated boosters this fall. This is what experts think of their prospects. 
Via Investor's Business Daily
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.